We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

LNA-based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit

News   Jun 16, 2009

 
LNA-based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
 
 
Advertisement
 

RELATED ARTICLES

Team Synthesizes Safer Nonaddictive Analgesics

News

A team has discovered a new class of drugs, capable of relieving pain and reducing fever without the danger of addiction or damage to the liver or kidneys.

READ MORE

A Watched Pot Never Boils… But That’s Not the Case With DNA

News

Liquid droplets formed from DNA display a peculiar response to enzymes. An international collaboration has now been able to explain the mechanisms behind bubble formation.

READ MORE

Compounds Target Key Enzyme Halting SARS-CoV-2 Replication

News

Researchers have identified several existing compounds that block replication of the COVID-19 virus (SARS-CoV-2) within human cells grown in the laboratory.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE